MXCT - Gene editing stocks slide after two-day rally
2023-11-21 15:13:40 ET
More on Beam, CRISPR, etc.
- Intellia: Soon-To-Be Enrollment Completion Brings About Catalysts In 2024
- Editas Medicine, Inc. (EDIT) Presents at Stifel 2023 Healthcare Conference (Transcript)
- Beam Therapeutics: Sale Of Rights To Verve's In Vivo Candidates An Odd Decision
- Gene editing stocks mixed despite world’s first CRISPR drug approval
- Biggest stock movers today: Alibaba, Walmart, Cisco Systems, Palo Alto Networks and more
For further details see:
Gene editing stocks slide after two-day rally